Stock 0RH2 EL.EN. S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings EL.En. S.p.A. London S.E.

Equities

0RH2

IT0005453250

Market Closed - London S.E.
Other stock markets
 01:38:40 15/04/2024 pm IST 		After market 01:13:28 am
11.88 EUR +24.74% Intraday chart for EL.En. S.p.A. 9.27 -21.94%
16/05 Transcript : EL.En. S.p.A., Q1 2024 Earnings Call, May 16, 2024
15/05 EL.En. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.96 for the current period. Therefore, the company is undervalued.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • Revenue estimates are regularly revised downwards for the current and coming years.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
EL.EN. S.P.A. Stock EL.En. S.p.A.
+21.11% 81Cr -
SISRAM MEDICAL LTD Stock Sisram Medical Ltd
-29.28% 23Cr -
LAMEDITECH CO., LTD. Stock LAMEDITECH Co., Ltd.
0.00% 14Cr - -
LASEROPTEK CO., LTD. Stock Laseroptek Co., Ltd.
-36.21% 7.44Cr - -
MODULIGHT OYJ Stock Modulight Oyj
+7.33% 5.58Cr -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ELN Stock
  4. 0RH2 Stock
  5. Ratings EL.En. S.p.A.